CpG 10103
Latest Information Update: 06 Jul 2006
At a glance
- Originator Coley Pharmaceutical Group
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Infections
Most Recent Events
- 30 Apr 2003 Preclinical trials in Infections in Canada (unspecified route)
- 30 Apr 2003 Preclinical trials in Infections in Germany (unspecified route)